ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Bio-Reference Laboratories, Inc." (BRLI) Report Updated: Oct 27, 2014 | Print This Page

Get more stock ratings by Louis Navellier

"Bio-Reference Laboratories, Inc." (BRLI)

Rating: Hold Volatility: Conservative
Total Grade: C Industry: Health Care Providers & Services
Competitors: MCK, DVA, HCA, LPNT

Stock Analysis

Rating: Monthly View

A
B
C
D
F
October November December January February March April May June July August September

Rating: Weekly View

This Week: C down no change
Last Week: C same no change
Two Weeks Ago: C up no change
service keys

"Bio-Reference Laboratories, Inc."© quotemedia

Company Profile

Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. The company offers chemical diagnostic tests, such as blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology, and other tissue analysis, as well as performs cancer cytogenetic testing. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional health care services. In addition, the company operates a clinical knowledge management service unit, which uses customer data from laboratory results, pharmaceutical data, claims data and other data sources to provide administrative and clinical decision support systems; and a Web-based connectivity portal solution for laboratories and physicians. Bio-Reference Laboratories, Inc. provides its services directly to physicians, geneticists, hospitals, clinics, and correctional and other health facilities. The company was founded in 1981 and is based in Elmwood Park, New Jersey.

Recent News: "Bio-Reference Laboratories, Inc."